As shown in Table 1, high HAX-1 expression was associated with lymph node metastasis (P < 0.01), M classification (P < 0.01), and clinical stage (P < 0.01). This evidence concerns the gene HAX1 and metastatic malignant neoplasm in the lymph nodes.